Get the Stockscreener App
1.63
1.88%
0.03
Regentis Biomaterials Ltd. stock is traded at $1.63, with a volume of 36,121.
It is up +1.88% in the last 24 hours and down -13.76% over the past month.
See More
Previous Close:
$1.60
Open:
$1.62
24h Volume:
36,121
Relative Volume:
0.71
Market Cap:
$11.45M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-2.40%
1M Performance:
-13.76%
6M Performance:
-47.42%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$1.60
$1.7398
52-Week Range:
$1.2316
$15.50
Regentis Biomaterials Ltd. Stock (RGNT) Company Profile
Name
Regentis Biomaterials Ltd.
Sector
Industry
Phone
-
Address
-
Compare RGNT vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGNT
Regentis Biomaterials Ltd.
|
1.63 | 11.45M | 0 | 0 | 0 | 0.00 |
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Regentis Biomaterials Ltd. Stock (RGNT) Latest News
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City - The Globe and Mail
A knee cartilage implant study is more than 50% enrolled - Stock Titan
Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage - Benzinga
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - benzinga.com
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - Barchart.com
REGENTIS BIOMATERIALS LTD. SEC Filing (Sep 23, 2026) - Stock Titan
Stray alert from IBN tagged to Regentis Biomaterials withdrawn - marketscreener.com
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd. - Yahoo Finance
Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair - Yahoo Finance
Regentis Biomaterials (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilag - Benzinga
Regentis Biomaterials Ltd. Research & Ratings | RGNT - Barron's
Regentis Biomaterials Ltd. Stock Grades | RGNT - Barron's
Regentis Biomaterials Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - marketscreener.com
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update - finance.yahoo.com
Regentis (NYSE American: RGNT) says cash lasts to 2027 but issues going‑concern warning - Stock Titan
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC - Yahoo Finance
Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks - Yahoo Finance
Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market - Yahoo Finance
Regentis Biomaterials Ltd. Revenue Breakdown – AMEX:RGNT - TradingView
Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - Yahoo Finance
Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - newmediawire.com
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process - Yahoo Finance
Regentis Biomaterials Ltd Actuals & Estimates (AMEX:RGNT) - TradingView
Why Is Regentis Biomaterials Stock Rising On Wednesday? - Benzinga
Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending - Benzinga
RGNT Stock Erupts As GelrinC European Rollout Plans Ignite Trading - StocksToTrade
Why Did RGNT Stock Surge More Than 850% Today? - Yahoo Finance
RGNT Stock Slides After Volatile Spike Draws Trader Focus - timothysykes.com
RGNT Stock Rockets On High-Volume Breakout Volatility - StocksToTrade
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC - Yahoo Finance
10-minute knee implant shows about 2x pain relief vs microfracture - stocktitan.net
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones - Yahoo Finance
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant - Yahoo Finance
RGNT - Finviz
Regentis Biomaterials (RGNT) Is 'One to Watch' - Yahoo Finance
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering - Yahoo Finance
Regentis Biomaterials Ltd. Stock (RGNT) Financials Data
There is no financial data for Regentis Biomaterials Ltd. (RGNT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
21.89%
12.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):